4//SEC Filing
Beckerle Mary C 4
Accession 0000939767-25-000027
CIK 0000939767other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 8:32 PM ET
Size
10.5 KB
Accession
0000939767-25-000027
Insider Transaction Report
Form 4
EXELIXIS, INC.EXEL
Beckerle Mary C
Director
Transactions
- Exercise/Conversion
Common Stock
2025-02-14$23.24/sh+8,354$194,147→ 42,616 total - Sale
Common Stock
2025-02-14$34.87/sh−8,354$291,304→ 34,262 total - Sale
Common Stock
2025-02-14$34.90/sh−3,856$134,574→ 30,406 total - Exercise/Conversion
Option (right to buy)
2025-02-14−8,354→ 22,494 totalExercise: $23.24From: 2024-01-05Exp: 2031-01-04→ Common Stock (8,354 underlying)
Footnotes (3)
- [F1]Includes 30,406 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
- [F2]Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $34.87 to $34.88. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
- [F3]The option, representing the right to purchase a total of 30,848 shares of Common Stock, became fully exercisable on January 5, 2024.
Documents
Issuer
EXELIXIS, INC.
CIK 0000939767
Entity typeother
Related Parties
1- filerCIK 0001520181
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 8:32 PM ET
- Size
- 10.5 KB